Home » Topics » Conferences

Conferences
RSS

Lilly's oral diarylsulfonylurea LY-295501 profiled at NCI-EORTC meeting

June 22, 1998

Symphar, SmithKline Beecham collaborate in the discovery of Lp(a)-lowering agents

June 22, 1998

Bay-12-9566: a promising anticancer compound progresses to phase III at Bayer

June 22, 1998

Russian scientists evaluate the antitumor activity of betaleukin

June 22, 1998

Telomerase inhibitors in early development at CRC

June 22, 1998

Sibutramine: preclinical effects on glucose homeostasis and uptake

June 19, 1998

EXO-226 effective against diabetic nephropathy in db/db mice

June 19, 1998

MD-700, a new LDL receptor-upregulating compound from Taisho

June 19, 1998

Hoe-901: new long-acting insulin for IDDM and NIDDM

June 19, 1998

New fluorinated anthracyclines from M.D. Anderson

June 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.